Canada markets closed

Vir Biotechnology, Inc. (VIR)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
26.70+2.24 (+9.16%)
At close: 04:00PM EDT
27.00 +0.30 (+1.12%)
After hours: 07:59PM EDT
Full screen
Trade prices are not sourced from all markets
Previous Close24.46
Bid26.05 x 1400
Ask26.65 x 800
Day's Range24.24 - 26.74
52 Week Range18.21 - 58.00
Avg. Volume1,654,123
Market Cap3.534B
Beta (5Y Monthly)-0.56
PE Ratio (TTM)2.97
EPS (TTM)8.99
Earnings DateAug 03, 2022 - Aug 08, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est52.71
  • GlobeNewswire

    Vir Biotechnology Reminds Stockholders of 2022 Annual General Meeting Details

    SAN FRANCISCO, May 18, 2022 (GLOBE NEWSWIRE) -- Vir Biotechnology, Inc. (Nasdaq: VIR) today reminds stockholders that it will hold its 2022 Annual General Meeting of Stockholders on Friday, May 20, 2022, at 11:30 a.m. PT. The Annual Meeting will be held in virtual format only via live audio webcast. Vir Biotechnology’s stockholders of record as of March 28, 2022 (the “Record Date”) can attend and vote at the Annual Meeting by accessing the meeting center at

  • Zacks

    AstraZeneca (AZN) Inks Deal to Develop COVID-19 Antibodies

    AstraZeneca (AZN) partners with a U.K.-based biotech company to develop monoclonal antibodies targeting the COVID-causing virus.

  • Zacks

    Vir Biotechnology, Inc. (VIR) Q1 Earnings and Revenues Beat Estimates

    Vir Biotechnology, Inc. (VIR) delivered earnings and revenue surprises of 19.94% and 80.87%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?